Sorafenib plus Hepatic Arterial Infusion Chemotherapy with Cisplatin vs. Sorafenib for Advanced Hepatocellular Carcinoma: Randomized Phase II Trial

In a randomized phase II study of sorafenib plus hepatic arterial infusion chemotherapy with cisplatin in comparison with sorafenib alone in patients with advanced hepatocellular carcinoma, it yielded favorable overall survival as compared to sorafenib. This is the first report of its effectiveness in relation to the overall survival in comparison with that of sorafenib in patients with advanced hepatocellular carcinoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2c4gNxL
via IFTTT